Although more than 500,000 hysterectomies are performed annually in the U.S. to treat benign pelvic diseases, most outcome studies of the procedure look at clinical factors such as operation time, surgical complications, and hospital stays while ignoring patient satisfaction and quality of life issues. Now, a new study published in Obstetrics & Gynecology has found that patients who receive laparoscopic hysterectomy may fare better than those who receive abdominal hysterectomy.
Although more than 500,000 hysterectomies are performed annually in the U.S. to treat benign pelvic diseases, most outcome studies of the procedure look at clinical factors such as operation time, surgical complications, and hospital stays while ignoring patient satisfaction and quality of life issues. Now, a new study published in Obstetrics & Gynecology has found that patients who receive laparoscopic hysterectomy may fare better than those who receive abdominal hysterectomy.
To better understand the impact of laparoscopic versus abdominal hysterectomies on long-term quality of life, Dr. Theodoor E. Nieboer, from the department of obstetrics and gynecology at Radboud University Nijmegen Medical Centre in Nijmegen, the Netherlands, and colleagues conducted a prospective, randomized controlled trial of women with benign gynecologic disease. All abdominal hysterectomies (N=32) were performed via standard extrafascial technique while laparoscopic hysterectomies (N=27) were all intentionally total laparoscopic hysterectomies. Participants were followed for a median of 4 years; at which point they were sent a general health-based survey to ascertain quality of life.
Overall, Nieboer and colleagues found that patients in the laparoscopic treatment group scored statistically higher on the self-assessment than their counterparts in the abdominal treatment group, which indicates the laparoscopic group fared better and reported higher quality of life. Nieboer et al. also noted that women who received laparoscopic surgery generally had better scores in domains such as vitality, physical functioning, and social functioning. However, the researchers failed to find significant differences for such items as general health, physical role functioning, emotional role functioning, social functioning, and mental health. Interestingly, in the early weeks after the surgery, the laparoscopic group scored higher in the bodily pain domain, but the difference was not statistically significant at 12 weeks and 4 years after surgery.
“The finding that quality of life is still better 4 years after laparoscopic hysterectomy is striking,” the authors wrote. “The benefits of avoiding laparotomy seem to work through after several years. Until now, laparoscopic hysterectomy has only proven to result in better quality of life until 6 and 12 weeks after surgery.”
Based on these results, Nieboer and colleagues concluded, “All patients listed for hysterectomy in whom vaginal hysterectomy is not possible and with a moderately enlarged uterus should be able to opt for laparoscopic hysterectomy.”
Reference:
Nieboer TE, Hendriks JC, Bongers MY, et al. Quality of life after laparoscopic and abdominal hysterectomy: a randomized controlled trial. Obstet Gynecol. 2012;119(1):85-91.
Advancing obstetric and gynecologic surgery through robotic innovation
April 30th 2024Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More